|
Volumn 9, Issue 5, 2015, Pages 405-410
|
Primary care-based Hepatitis C treatment outcomes with first-generation direct-acting agents
|
Author keywords
antiviral therapy; health services research; hepatitis C; outcomes; primary care; substance abuse
|
Indexed keywords
ANTIRETROVIRUS AGENT;
BOCEPREVIR;
PEGINTERFERON;
RIBAVIRIN;
TELAPREVIR;
ALPHA INTERFERON;
ANTIVIRUS AGENT;
MACROGOL DERIVATIVE;
N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE;
OLIGOPEPTIDE;
PEGINTERFERON ALPHA2A;
PROLINE;
RECOMBINANT PROTEIN;
ADULT;
ARTICLE;
COHORT ANALYSIS;
COMORBIDITY;
CONTROLLED STUDY;
DISEASE SEVERITY;
FEMALE;
GENOTYPE;
HEALTH CARE ACCESS;
HEALTH SERVICE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LIVER FIBROSIS;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
PREVALENCE;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
SUBSTANCE USE;
TREATMENT OUTCOME;
URBAN POPULATION;
ANALOGS AND DERIVATIVES;
COMBINATION DRUG THERAPY;
COMPLICATION;
DRUG EFFECTS;
FACTUAL DATABASE;
HEPATITIS C, CHRONIC;
MIDDLE AGED;
PRIMARY HEALTH CARE;
SUBSTANCE-RELATED DISORDERS;
VIRUS LOAD;
ANTIVIRAL AGENTS;
DATABASES, FACTUAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
MALE;
MIDDLE AGED;
OLIGOPEPTIDES;
POLYETHYLENE GLYCOLS;
PRIMARY HEALTH CARE;
PROLINE;
RECOMBINANT PROTEINS;
RIBAVIRIN;
SUBSTANCE-RELATED DISORDERS;
TREATMENT OUTCOME;
VIRAL LOAD;
|
EID: 84957102793
PISSN: 19320620
EISSN: 19353227
Source Type: Journal
DOI: 10.1097/ADM.0000000000000147 Document Type: Article |
Times cited : (16)
|
References (0)
|